Table 3.

Correlation between phenotypic characteristics of myeloid dendritic cells (mDCs) with different clinical parameters.

Plasmacytoid dendritic cells
Clinical parameter		% LINnegHLA − DR + CD11c−	% LINneg HLA − DR + CD11c− BDCA4+	% CD80	CD80 (MFI)	%CD86	CD86 (MFI)	%CD40	CD40 (MFI)
LVEF (%)	r	0.424	0.303	−0.052	−0.273	−0.188	−0.284	0.065	−0.348
	p	0.102	0.290	0.834	0.304	0.508	0.310	0.828	0.235
CK-MB (ng/mL)	r	0.159	0.629	0.314	0.225	0.165	0.392	−0.240	0.005
	p	0.554	∗ 0.0317	0.254	0.416	0.573	0.166	0.409	0.993
Troponin-I (ng/mL)	r	−0.066	0.661	0.424	0.084	0.608	1.000	−0.071	0.273
	p	0.817	∗ 0.0438	0.132	0.776	∗0.0399	∗∗∗ 0.0001	0.821	0.391
CRP (mg/L)	r	0.060	−0.266	0.214	0.467	0.213	0.130	0.152	0.615
	p	0.824	0.357	0.442	0.081	0.464	0.656	0.605	∗ 0.0284
CET (days)	r	−0.260	−0.394	−0.407	−0.141	−0.628	−0.194	−0.086	−0.009
	p	0.234	0.100	0.087	0.488	∗∗ 0.0093	0.369	0.632	0.828
IET (days)	r	0.061	−0.454	−0.161	0.270	−0.454	−0.039	0.305	0.361
	p	0.844	0.147	0.575	0.370	0.128	0.845	0.305	0.278

LVEF: left ventricular ejection fraction; CK-MB: creatine kinase; CET: cardiovascular disease evolution time,; CRP: C-reactive protein; IET: infection evolution time; r: correlation coefficient; p: probability value. ^∗p < 0.05, ^∗∗p < 0.01, and^∗∗∗p < 0.001.